Patents

US 11021752 B2: Genes and gene signatures for diagnosis and treatment of melanoma

Granted
2021-06-01
Filed
2014-03-12 application 14205965
Type
Utility · 10 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.

Source: PVGPATDIS, file of 2026-04-10 (ipg210601.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Myriad Genetics, Inc. 41 patentsUS company or organizationSalt Lake City, UTMYRIAD GENETICS , INC. State business registration EXACT high confidence: identical full name and state
MYRIAD GENETICS INC Form D issuer EXACT high confidence: identical full name and state
MYRIAD GENETICS INC SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Michael Bryan WarfSalt Lake City, UT5PVGPATDIS, file of 2026-04-10
Benjamin RoaSalt Lake City, UT6PVGPATDIS, file of 2026-04-10
Alexander GutinSalt Lake City, UT33PVGPATDIS, file of 2026-04-10
Darl FlakeSalt Lake City, UT6PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processesC12Q1/6886PVGPATDIS, file of 2026-04-10
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biologyG16B20/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2023-07-10Release of security interest
Release of security interest
JPMORGAN CHASE BANK, N.A. signed 2023-06-30MYRIAD GENETICS, INC. SALT LAKE CITY, UT
CRESCENDO BIOSCENCE, INC. SALT LAKE CITY, UT
MYRIAD RBM, INC. SALT LAKE CITY, UT
MYRIAD WOMEN'S HEALTH, INC. SALT LAKE CITY, UT
64239/91PASDL, file of 2026-10-15
2021-05-21Assignment
Assignment of assignor's interest
MYRIAD GENETICS, INC. signed 2021-05-10MYRIAD MYPATH, LLC SALT LAKE CITY, UT56312/897PASDL, file of 2026-10-15
2016-12-27Security interest Security interest
Security interest
MYRIAD GENETICS, INC. signed 2016-12-23JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT CHICAGO, IL41198/578PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.